MAP Kinase Inhibitors in Inflammation and Autoimmune Disorders

被引：8

作者：

Bhagwat, Shripad S. ^{[1
]}

机构：

[1] Ambit Biosci, San Diego, CA 92121 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷

关键词：

D O I：

10.1016/S0065-7743(07)42017-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：265 / 278

页数：14

共 50 条

[1] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
Shripad S. Bhagwat
Purinergic Signalling, 2009, 5
[2] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
Bhagwat, Shripad S.
PURINERGIC SIGNALLING, 2009, 5 (01) : 107 - 115
[3] Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
Moreker, Mayur R.
INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) : 1939 - 1940
[4] Map kinase inhibitors
不详
CHIMICA OGGI-CHEMISTRY TODAY, 1998, 16 (1-2) : 50 - 50
[5] Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders
Abdel-Magid, Ahmed F.
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (01): : 18 - 19
[6] IκB kinase inhibitors for treating autoimmune and inflammatory disorders:: potential and challenges
Strnad, Joann
Burke, James R.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (03) : 142 - 148
[7] Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: A review
Kaur, Maninder
Singh, Manjinder
Silakari, Om
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 : 434 - 446
[8] Kinase Inhibitors For Autoimmune and Inflammatory Diseases
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (01) : 15 - 15
[9] Janus kinase inhibitors in autoimmune diseases
O'Shea, John J.
Kontzias, Apostolos
Yamaoka, Kunihiro
Tanaka, Yoshiya
Laurence, Arian
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 111 - 115
[10] Discovering new MAP kinase inhibitors
Shapiro, Paul
CHEMISTRY & BIOLOGY, 2006, 13 (08): : 807 - 809

← 1 2 3 4 5 →